Literature DB >> 25455024

Analyzing the blood-brain barrier: the benefits of medical imaging in research and clinical practice.

Yoash Chassidim1, Udi Vazana1, Ofer Prager1, Ronel Veksler1, Guy Bar-Klein1, Karl Schoknecht2, Michael Fassler1, Svetlana Lublinsky1, Ilan Shelef3.   

Abstract

A dysfunctional BBB is a common feature in a variety of brain disorders, a fact stressing the need for diagnostic tools designed to assess brain vessels' permeability in space and time. Biological research has benefited over the years various means to analyze BBB integrity. The use of biomarkers for improper BBB functionality is abundant. Systemic administration of BBB impermeable tracers can both visualize brain regions characterized by BBB impairment, as well as lead to its quantification. Additionally, locating molecular, physiological content in regions from which it is restricted under normal BBB functionality undoubtedly indicates brain pathology-related BBB disruption. However, in-depth research into the BBB's phenotype demands higher analytical complexity than functional vs. pathological BBB; criteria which biomarker based BBB permeability analyses do not meet. The involvement of accurate and engineering sciences in recent brain research, has led to improvements in the field, in the form of more accurate, sensitive imaging-based methods. Improvements in the spatiotemporal resolution of many imaging modalities and in image processing techniques, make up for the inadequacies of biomarker based analyses. In pre-clinical research, imaging approaches involving invasive procedures, enable microscopic evaluation of BBB integrity, and benefit high levels of sensitivity and accuracy. However, invasive techniques may alter normal physiological function, thus generating a modality-based impact on vessel's permeability, which needs to be corrected for. Non-invasive approaches do not affect proper functionality of the inspected system, but lack in spatiotemporal resolution. Nevertheless, the benefit of medical imaging, even in pre-clinical phases, outweighs its disadvantages. The innovations in pre-clinical imaging and the development of novel processing techniques, have led to their implementation in clinical use as well. Specialized analyses of vessels' permeability add valuable information to standard anatomical inspections which do not take the latter into consideration.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Biomarkers; Blood–brain barrier; Clinical imaging modalities; Invasive/non-invasive pre-clinical imaging modalities

Mesh:

Year:  2014        PMID: 25455024     DOI: 10.1016/j.semcdb.2014.11.007

Source DB:  PubMed          Journal:  Semin Cell Dev Biol        ISSN: 1084-9521            Impact factor:   7.727


  5 in total

Review 1.  Pharmacokinetic Properties of Anticancer Agents for the Treatment of Central Nervous System Tumors: Update of the Literature.

Authors:  Megan O Jacus; Vinay M Daryani; K Elaine Harstead; Yogesh T Patel; Stacy L Throm; Clinton F Stewart
Journal:  Clin Pharmacokinet       Date:  2016-03       Impact factor: 6.447

Review 2.  Blood-brain barrier permeability imaging as a predictor for delayed cerebral ischaemia following subarachnoid haemorrhage. A narrative review.

Authors:  Michael Amoo; Jack Henry; Niall Pender; Paul Brennan; Matthew Campbell; Mohsen Javadpour
Journal:  Acta Neurochir (Wien)       Date:  2021-01-06       Impact factor: 2.216

3.  Glutamate-Mediated Blood-Brain Barrier Opening: Implications for Neuroprotection and Drug Delivery.

Authors:  Udi Vazana; Ronel Veksler; Gaby S Pell; Ofer Prager; Michael Fassler; Yoash Chassidim; Yiftach Roth; Hamutal Shahar; Abraham Zangen; Ruggero Raccah; Emanuela Onesti; Marco Ceccanti; Claudio Colonnese; Antonio Santoro; Maurizio Salvati; Alessandro D'Elia; Valter Nucciarelli; Maurizio Inghilleri; Alon Friedman
Journal:  J Neurosci       Date:  2016-07-20       Impact factor: 6.167

4.  ZW800-1 for Assessment of Blood-Brain Barrier Disruption in a Photothrombotic Stroke Model.

Authors:  Sungsu Lee; Wonbong Lim; Hye-Won Ryu; Danbi Jo; Jung-Joon Min; Hyung-Seok Kim; Hoon Hyun
Journal:  Int J Med Sci       Date:  2017-11-02       Impact factor: 3.738

Review 5.  Neurosurgical Techniques for Disruption of the Blood-Brain Barrier for Glioblastoma Treatment.

Authors:  Analiz Rodriguez; Stephen B Tatter; Waldemar Debinski
Journal:  Pharmaceutics       Date:  2015-08-03       Impact factor: 6.321

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.